Clinigence Holdings Inc (NUTX)
NASDAQ:NUTX
Want to see NUTX full AI Analyst Report?
Total Valuation
Clinigence Holdings has a market cap or net worth of $858.10M. The enterprise value is $894.31M.
Market Cap$858.10M
Enterprise Value$894.31M
Share Statistics
Clinigence Holdings has 6,881,339 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,881,339
Owned by Insiders31.73%
Owned by Institutions11.89%
Financial Efficiency
Clinigence Holdings’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 25.91%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)25.91%
Return on Capital Employed (ROCE)0.36
Revenue Per Employee1.09M
Profits Per Employee225.45K
Employee Count800
Asset Turnover0.95
Inventory Turnover150.38
Valuation Ratios
The current PE Ratio of Clinigence Holdings is 3.4. Clinigence Holdings’s PEG ratio is 1.68.
PE Ratio3.4
PS Ratio1.20
PB Ratio3.18
Price to Fair Value3.18
Price to FCF4.26
Price to Operating Cash Flow3.11
PEG Ratio1.68
Income Statement
In the last 12 months, Clinigence Holdings had revenue of 875.26M and earned 70.79M in profits. Earnings per share was 11.13.
Revenue875.26M
Gross Profit444.28M
Operating Income275.63M
Pretax Income244.78M
Net Income70.79M
EBITDA287.54M
Earnings Per Share (EPS)11.13
Cash Flow
In the last 12 months, operating cash flow was 272.68M and capital expenditures -3.66M, giving a free cash flow of 269.01M billion.
Operating Cash Flow272.68M
Free Cash Flow269.01M
Free Cash Flow per Share39.09
Dividends & Yields
Clinigence Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.11
52-Week Price Change-25.21%
50-Day Moving Average109.11
200-Day Moving Average118.68
Relative Strength Index (RSI)53.81
Average Volume (3m)182.88K
Important Dates
Clinigence Holdings upcoming earnings date is Aug 6, 2026, After Close (Confirmed).
Last Earnings DateApr 30, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Clinigence Holdings as a current ratio of 3.41, with Debt / Equity ratio of 100.81%
Current Ratio3.41
Quick Ratio3.39
Debt to Market Cap0.04
Net Debt to EBITDA0.58
Interest Coverage Ratio12.40
Taxes
In the past 12 months, Clinigence Holdings has paid 64.42M in taxes.
Income Tax64.42M
Effective Tax Rate0.26
Enterprise Valuation
Clinigence Holdings EV to EBITDA ratio is 4.22, with an EV/FCF ratio of 4.94.
EV to Sales1.39
EV to EBITDA4.22
EV to Free Cash Flow4.94
EV to Operating Cash Flow4.89
Balance Sheet
Clinigence Holdings has $207.35M in cash and marketable securities with $349.09M in debt, giving a net cash position of -$141.74M billion.
Cash & Marketable Securities$207.35M
Total Debt$349.09M
Net Cash-$141.74M
Net Cash Per Share-$20.60
Tangible Book Value Per Share$61.04
Margins
Gross margin is 47.47%, with operating margin of 31.49%, and net profit margin of 8.09%.
Gross Margin47.47%
Operating Margin31.49%
Pretax Margin27.97%
Net Profit Margin8.09%
EBITDA Margin32.85%
EBIT Margin30.51%
Analyst Forecast
The average price target for Clinigence Holdings is $237.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$237.50
Price Target Upside29.00% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast40.95%
EPS Growth Forecast4.15%